Long intergenic non-protein coding RNA 3105 (LINC03105)

LINC03105 is a human long intergenic non-coding RNA (lincRNA) gene, meaning it transcribes RNA molecules longer than 200 nucleotides that do not overlap with, or code for, proteins[1][3][5]. lincRNAs are recognized for their regulatory functions at the transcriptional and epigenetic levels, including the modulation of gene expression, chromatin state, and potentially acting as scaffolds for protein complexes involved in gene regulation. The majority of human lincRNAs, including LINC03105, have not been thoroughly functionally characterized. Canonical lincRNA activities include cis or trans gene expression modulation, enhancer-like functions, and chromatin architecture control[3][5][7]. There is no evidence as of now that LINC03105 is a direct therapeutic drug target, nor is it associated with any specific pathology, drug interactions, or established biomarker roles in clinical practice[1]. \n\nKey clarification: \nLINC03105 is not a receptor, enzyme, transporter, transcription factor, or otherwise recognized canonical therapeutic target. It is a non-coding RNA gene with potential gene regulatory roles, similar to other lincRNAs, but with no specific, experimentally validated disease functions or therapeutic relevance currently documented in major scientific databases[1][3][5].\n\nIf you seek information about disease relevance, biomarkers, or drug targeting, this gene does not yet meet those criteria. If you believe the name may be erroneous or meant to refer to a protein-coding gene, please clarify, as LINC03105 is accurately annotated as a non-protein-coding, intergenic RNA gene[1].

Other names

LINC03105

Not applicable (no drugs or direct therapeutic targeting reported)